ATAI ATAI Life Sciences NV

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATAI

Price (delayed)

$1.93

Market cap

$320.43M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.25

Enterprise value

$294.54M

Highlights
The net income has soared by 74% YoY and by 40% from the previous quarter
ATAI's EPS has soared by 74% year-on-year and by 42% since the previous quarter
ATAI Life Sciences's revenue has increased by 35% YoY but it has decreased by 6% QoQ
The company's gross profit rose by 35% YoY but it fell by 6% QoQ
ATAI's quick ratio is down by 35% year-on-year and by 16% since the previous quarter
The debt is up by 25% year-on-year and by 15% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: FC UTI GHC

Key stats

What are the main financial stats of ATAI
Market
Shares outstanding
166.03M
Market cap
$320.43M
Enterprise value
$294.54M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.32
Price to sales (P/S)
976.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
938.02
Earnings
Revenue
$314,000
EBIT
-$36.55M
EBITDA
-$35.85M
Free cash flow
-$84.71M
Per share
EPS
-$0.25
Free cash flow per share
-$0.53
Book value per share
$1.46
Revenue per share
$0
TBVPS
$1.85
Balance sheet
Total assets
$293.48M
Total liabilities
$49.16M
Debt
$19.14M
Equity
$242.96M
Working capital
$165.47M
Liquidity
Debt to equity
0.08
Current ratio
9.22
Quick ratio
8.93
Net debt/EBITDA
0.72
Margins
EBITDA margin
-11,417.2%
Gross margin
100%
Net margin
-12,810.2%
Operating margin
-39,958.9%
Efficiency
Return on assets
-14.2%
Return on equity
-16.8%
Return on invested capital
-21.5%
Return on capital employed
-13.4%
Return on sales
-11,640.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATAI stock price

How has the ATAI Life Sciences stock price performed over time
Intraday
4.89%
1 week
4.32%
1 month
11.56%
1 year
3.21%
YTD
36.88%
QTD
-2.03%

Financial performance

How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$314,000
Gross profit
$314,000
Operating income
-$125.47M
Net income
-$40.22M
Gross margin
100%
Net margin
-12,810.2%
The net margin has surged by 80% year-on-year and by 36% since the previous quarter
The net income has soared by 74% YoY and by 40% from the previous quarter
ATAI Life Sciences's operating margin has increased by 36% YoY but it has decreased by 3.1% from the previous quarter
ATAI Life Sciences's revenue has increased by 35% YoY but it has decreased by 6% QoQ

Growth

What is ATAI Life Sciences's growth rate over time

Valuation

What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
1.32
P/S
976.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
938.02
ATAI's EPS has soared by 74% year-on-year and by 42% since the previous quarter
The P/B is 20% more than the last 4 quarters average of 1.1
The equity has declined by 9% since the previous quarter and by 7% year-on-year
ATAI Life Sciences's revenue has increased by 35% YoY but it has decreased by 6% QoQ
ATAI's P/S is 17% above its last 4 quarters average of 838.0

Efficiency

How efficient is ATAI Life Sciences business performance
ATAI's ROS has soared by 81% year-on-year and by 32% since the previous quarter
The company's return on invested capital has surged by 71% YoY and by 49% QoQ
ATAI's ROA has soared by 68% year-on-year and by 39% since the previous quarter
The company's return on equity has surged by 67% YoY and by 39% QoQ

Dividends

What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATAI.

Financial health

How did ATAI Life Sciences financials performed over time
The current ratio has contracted by 36% YoY and by 16% from the previous quarter
ATAI's quick ratio is down by 35% year-on-year and by 16% since the previous quarter
The debt is 92% smaller than the equity
The company's debt to equity rose by 33% QoQ and by 33% YoY
The debt is up by 25% year-on-year and by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.